BRWA
ANIX icon

B. Riley Wealth Advisors’s Anixa Biosciences ANIX Stock Holding History

B. Riley Wealth Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,200
Closed -$65.4K – 1541
2023
Q1 		$65.4K Hold
15,200
– – ﹤0.01% 1422
2022
Q4 		$64.6K Sell
15,200
-1,000
-6% -$4.81K ﹤0.01% 1396
2022
Q3 		$80K Buy
+16,200
New +$65.6K ﹤0.01% 1349

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

B. Riley Wealth Advisors's ANIX Position: Q2 2023 in Review

B. Riley Wealth Advisors sold out of Anixa Biosciences (ANIX) in Q2 2023, closing a stake of 15,200 shares — an estimated $65.4K sold.

B. Riley Wealth Advisors first reported a position in ANIX in Q3 2022 and held it in 3 quarters. The position peaked at $80K in Q3 2022. 45 funds tracked by Wall St. Rank hold ANIX as of Q2 2023.

  • B. Riley Wealth Advisors reported no remaining Anixa Biosciences position as of Q2 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 15,200 Anixa Biosciences shares in Q2 2023, an estimated $65.4K.
  • B. Riley Wealth Advisors first reported a position in Anixa Biosciences in Q3 2022 and held it in 3 quarters.
  • B. Riley Wealth Advisors's Anixa Biosciences position peaked at $80K in Q3 2022.
  • 45 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2023, filed 27 Jul 2023.